Plasma Angiopoietin-2 in Clinical Acute Lung Injury: Prognostic and Pathogenetic Significance

Overview

Journal Crit Care Med

Specialties Critical Care
Emergency Medicine

Date 2012 May 22

PMID 22610178

Citations 135

Authors

Carolyn S Calfee

Diana Gallagher

Jason Abbott

B Taylor Thompson

Michael A Matthay

Affiliations

Soon will be listed here.

Abstract

Background: Angiopoietin-2 is a proinflammatory mediator of endothelial injury in animal models, and increased plasma angiopoietin-2 levels are associated with poor outcomes in patients with sepsis-associated acute lung injury. Whether angiopoietin-2 levels are modified by treatment strategies in patients with acute lung injury is unknown.

Objectives: To determine whether plasma angiopoietin-2 levels are associated with clinical outcomes and affected by fluid management strategy in a broad cohort of patients with acute lung injury.

Design, Setting, And Participants: Plasma levels of angiopoietin-2 and von Willebrand factor (a traditional marker of endothelial injury) were measured in 931 subjects with acute lung injury enrolled in a randomized trial of fluid liberal vs. fluid conservative management.

Measurements And Main Results: The presence of infection (sepsis or pneumonia) as the primary acute lung injury risk factor significantly modified the relationship between baseline angiopoietin-2 levels and mortality (p = .01 for interaction). In noninfection-related acute lung injury, higher baseline angiopoietin-2 levels were strongly associated with increased mortality (odds ratio, 2.43 per 1-log increase in angiopoietin-2; 95% confidence interval, 1.57-3.75; p < .001). In infection-related acute lung injury, baseline angiopoietin-2 levels were similarly elevated in survivors and nonsurvivors; however, patients whose plasma angiopoietin-2 levels increased from day 0 to day 3 had more than double the odds of death compared with patients whose angiopoietin-2 levels declined over the same period of time (odds ratio, 2.29; 95% confidence interval, 1.54-3.43; p < .001). Fluid-conservative therapy led to a 15% greater decline in angiopoietin-2 levels from day 0 to day 3 (95% confidence interval, 4.6-24.8%; p = .006) compared with fluid-liberal therapy in patients with infection-related acute lung injury. In contrast, plasma levels of von Willebrand factor were significantly associated with mortality in both infection-related and noninfection-related acute lung injury and were not affected by fluid therapy.

Conclusions: Unlike von Willebrand factor, plasma angiopoietin-2 has differential prognostic value for mortality depending on the presence or absence of infection as an acute lung injury risk factor. Fluid conservative therapy preferentially lowers plasma angiopoietin-2 levels over time and thus may be beneficial in part by decreasing endothelial inflammation.

Citing Articles

Correlations between primary tumour location, biomarkers of inflammation and lung injury, and postoperative pulmonary complications in patients underwent laparoscopic colorectomy: a propensity score matched analysis of 300 patients.

Li H, Che L, Li Y, Wang T, Min F, Xu L Front Immunol. 2025; 16:1546167.

PMID: 39949769 PMC: 11821553. DOI: 10.3389/fimmu.2025.1546167.

Fluid Overload in Pediatric Acute Respiratory Distress Syndrome after Allogeneic Hematopoietic Cell Transplantation.

Sallee C, Fitzgerald J, Smith L, Angelo J, Daniel M, Gertz S J Pediatr Intensive Care. 2024; 13(3):286-295.

PMID: 39629158 PMC: 11379529. DOI: 10.1055/s-0042-1757480.

Angiopoietin II in Critically Ill Septic Patients: A Post Hoc Analysis of the DRAK Study.

Bucher V, Graf H, Zander J, Liebchen U, Hackner D, Grafe C Biomedicines. 2024; 12(11).

PMID: 39595003 PMC: 11591998. DOI: 10.3390/biomedicines12112436.

Cellular Mechanisms of Lung Injury: Current Perspectives.

Meegan J, Rizzo A, Schmidt E, Bastarache J Clin Chest Med. 2024; 45(4):821-833.

PMID: 39443000 PMC: 11499619. DOI: 10.1016/j.ccm.2024.08.004.

Fluid bolus increases plasma hyaluronan concentration compared to follow-up strategy without a bolus in oliguric intensive care unit patients.

Serlo M, Inkinen N, Lakkisto P, Valkonen M, Pulkkinen A, Selander T Sci Rep. 2024; 14(1):20808.

PMID: 39242877 PMC: 11379687. DOI: 10.1038/s41598-024-71670-2.

References

Wiedemann H, Wheeler A, Bernard G, Thompson B, Hayden D, deBoisblanc B . Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006; 354(24):2564-75. DOI: 10.1056/NEJMoa062200. View

Orfanos S, Mavrommati I, Korovesi I, Roussos C . Pulmonary endothelium in acute lung injury: from basic science to the critically ill. Intensive Care Med. 2004; 30(9):1702-14. DOI: 10.1007/s00134-004-2370-x. View

Parikh S, Mammoto T, Schultz A, Yuan H, Christiani D, Karumanchi S . Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med. 2006; 3(3):e46. PMC: 1334221. DOI: 10.1371/journal.pmed.0030046. View

Ricciuto D, Santos C, Hawkes M, Toltl L, Conroy A, Rajwans N . Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis. Crit Care Med. 2011; 39(4):702-10. DOI: 10.1097/CCM.0b013e318206d285. View

Roviezzo F, Tsigkos S, Kotanidou A, Bucci M, Brancaleone V, Cirino G . Angiopoietin-2 causes inflammation in vivo by promoting vascular leakage. J Pharmacol Exp Ther. 2005; 314(2):738-44. DOI: 10.1124/jpet.105.086553. View

Eisner M, Thompson T, Hudson L, Luce J, Hayden D, Schoenfeld D . Efficacy of low tidal volume ventilation in patients with different clinical risk factors for acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001; 164(2):231-6. DOI: 10.1164/ajrccm.164.2.2011093. View

Bhandari V, Choo-Wing R, Lee C, Zhu Z, Nedrelow J, Chupp G . Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death. Nat Med. 2006; 12(11):1286-93. PMC: 2768268. DOI: 10.1038/nm1494. View

Rubin D, Wiener-Kronish J, Murray J, Green D, Turner J, Luce J . Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome. J Clin Invest. 1990; 86(2):474-80. PMC: 296749. DOI: 10.1172/JCI114733. View

van der Heijden M, Pickkers P, van Nieuw Amerongen G, van Hinsbergh V, Bouw M, van der Hoeven J . Circulating angiopoietin-2 levels in the course of septic shock: relation with fluid balance, pulmonary dysfunction and mortality. Intensive Care Med. 2009; 35(9):1567-74. PMC: 2726915. DOI: 10.1007/s00134-009-1560-y. View

10.

Gallagher D, Parikh S, Balonov K, Miller A, Gautam S, Talmor D . Circulating angiopoietin 2 correlates with mortality in a surgical population with acute lung injury/adult respiratory distress syndrome. Shock. 2007; 29(6):656-61. PMC: 4037741. DOI: 10.1097/shk.0b013e31815dd92f. View

11.

Kuebler W, Ying X, Singh B, Issekutz A, Bhattacharya J . Pressure is proinflammatory in lung venular capillaries. J Clin Invest. 1999; 104(4):495-502. PMC: 408527. DOI: 10.1172/JCI6872. View

12.

Flori H, Ware L, Milet M, Matthay M . Early elevation of plasma von Willebrand factor antigen in pediatric acute lung injury is associated with an increased risk of death and prolonged mechanical ventilation. Pediatr Crit Care Med. 2007; 8(2):96-101. PMC: 3586228. DOI: 10.1097/01.PCC.0000257097.42640.6F. View

13.

Meyer N, Li M, Feng R, Bradfield J, Gallop R, Bellamy S . ANGPT2 genetic variant is associated with trauma-associated acute lung injury and altered plasma angiopoietin-2 isoform ratio. Am J Respir Crit Care Med. 2011; 183(10):1344-53. PMC: 3114062. DOI: 10.1164/rccm.201005-0701OC. View

14.

Ong T, McClintock D, Kallet R, Ware L, Matthay M, Liu K . Ratio of angiopoietin-2 to angiopoietin-1 as a predictor of mortality in acute lung injury patients. Crit Care Med. 2010; 38(9):1845-51. PMC: 4009623. DOI: 10.1097/CCM.0b013e3181eaa5bf. View

15.

Ware L, Matthay M . The acute respiratory distress syndrome. N Engl J Med. 2000; 342(18):1334-49. DOI: 10.1056/NEJM200005043421806. View

16.

Romani De Wit T, Rondaij M, Hordijk P, Voorberg J, van Mourik J . Real-time imaging of the dynamics and secretory behavior of Weibel-Palade bodies. Arterioscler Thromb Vasc Biol. 2003; 23(5):755-61. DOI: 10.1161/01.ATV.0000069847.72001.E8. View

17.

Wheeler A, Bernard G, Thompson B, Schoenfeld D, Wiedemann H, deBoisblanc B . Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med. 2006; 354(21):2213-24. DOI: 10.1056/NEJMoa061895. View

18.

Knaus W, Wagner D, Draper E, Zimmerman J, Bergner M, Bastos P . The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest. 1991; 100(6):1619-36. DOI: 10.1378/chest.100.6.1619. View

19.

van der Heijden M, van Nieuw Amerongen G, Koolwijk P, van Hinsbergh V, Groeneveld A . Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients. Thorax. 2008; 63(10):903-9. DOI: 10.1136/thx.2007.087387. View

20.

Ochoa C, Wu S, Stevens T . New developments in lung endothelial heterogeneity: Von Willebrand factor, P-selectin, and the Weibel-Palade body. Semin Thromb Hemost. 2010; 36(3):301-8. PMC: 2917989. DOI: 10.1055/s-0030-1253452. View